A Pilot, Single-Center, Retrospective Case-Control Analysis To Identify Predictive Factors For Sustained Viral Response (SVR12) Failure Including Rapid Viral Response (RVR) In Patients With Hepatitis C Virus (HCV) Infection Receiving Ledipasvir and Sofosbuvir (LDV/SOF).
Phase of Trial: Phase IV
Latest Information Update: 01 Feb 2017
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 01 Feb 2017 Results assessing predictive factors for sustained viral response (SVR12) failure, published in the Annals of Pharmacotherapy.
- 27 Dec 2016 New trial record
- 30 Oct 2016 Results presented at the IDWeek 2016